source
- Flagship-backed Valo Health merges with Montai Therapeutics to boost AI-driven drug pipelineValo Health and Montai Therapeutics announced they will combine under the Valo brand, creating a larger AI-focused biotech aimed at accelerating early-stage drug discovery. Valo, launched in 2020…
- Dual targeting of GPCRs and mutated Gαq/11 shows promise for uveal melanomaResearchers at Thomas Jefferson University reported a new strategy to disrupt signaling in uveal melanoma, a rare eye cancer. The study found that simultaneously inhibiting the G protein-coupled r…